PGEN compared with NVCT: revenue, margins and what each company keeps, and the suppliers and customers both name

PGENPrecigen, Inc.

Mkt capRevenueRevenue

NVCTNuvectis Pharma, Inc.

Mkt capRevenueRevenue

Compare

PGENPrecigen, Inc.

NVCTNuvectis Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PGEN 8

PTCTPTC Therapeuticscustomer

—University of Texas MD Anderson Cancer Centerunlistedsupplier

—Eversanaunlistedsupplier

—National Cancer Institute (NCI)unlistedsupplier

4 more · PGEN chain ›

Shared 0

No shared counterparties.

Only NVCT 4

—CRT Pioneer Fundunlistedsupplier

—ICRunlistedsupplier

—University of Edinburghunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

UoE

unlistedsupplier

PGENPrecigen, Inc.

5.14▼−25.95%· post 5.19

Mkt cap$1.8BRevenue$55MQ2 FY26Revenue$10MFY25

NVCTNuvectis Pharma, Inc.

19.12▲+3.46%· post 19.29

ClosedNov 2 '26

Mkt cap$602.1MRevenue—Revenue—

Compare

ClosedNov 2 '26

PGENPrecigen, Inc.

NVCTNuvectis Pharma, Inc.

5.14▼−25.95%post 5.19

Price

19.12▲+3.46%post 19.29

$1.8B

Mkt cap

$602.1M

Q2 FY26$55M

Revenue

—

FY25$10M

Revenue

—

PGEN5.14▼−25.95%vsNVCT19.12▲+3.46%ClosedNov 2 '26